Holen Sie sich die Stockscreener-App
2.60
0.78%
0.02
Handel nachbörslich:
2.60
Schlusskurs vom Vortag:
$2.58
Offen:
$2.57
24-Stunden-Volumen:
305.56K
Relative Volume:
0.23
Marktkapitalisierung:
$185.40M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-192.96M
KGV:
-0.7879
EPS:
-3.3
Netto-Cashflow:
$-167.04M
1W Leistung:
+6.12%
1M Leistung:
-4.41%
6M Leistung:
+78.08%
1J Leistung:
+20.37%
1-Tages-Spanne:
$2.485
$2.61
1-Wochen-Bereich:
$2.31
$2.6199
52-Wochen-Spanne:
$0.783
$3.39
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Firmenname
Ventyx Biosciences Inc
Sektor
Branche
Telefon
(858) 945-2393
Adresse
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Vergleichen Sie VTYX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
2.60 | 175.42M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-12 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-03-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2023-11-07 | Herabstufung | Stifel | Buy → Hold |
| 2023-11-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-06-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2023-03-21 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Buy |
| 2022-11-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-09-07 | Eingeleitet | Stifel | Buy |
| 2022-09-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-09 | Eingeleitet | Credit Suisse | Outperform |
| 2022-03-31 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-15 | Eingeleitet | Jefferies | Buy |
| 2021-11-15 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Ventyx Biosciences Inc Aktie (VTYX) Neueste Nachrichten
Can Ventyx Biosciences Inc. lead its sector in growthQuarterly Portfolio Report & Long-Term Growth Stock Strategies - khodrobank.com
How to forecast Ventyx Biosciences Inc. trends using time seriesWeekly Trend Recap & Technical Pattern Based Signals - Newser
Quantitative breakdown of Ventyx Biosciences Inc. recent moveBear Alert & Daily Price Action Insights - Newser
Identifying reversal signals in Ventyx Biosciences Inc.2025 Market Overview & Precise Swing Trade Entry Alerts - Newser
What Fibonacci levels say about Ventyx Biosciences Inc. reboundWeekly Gains Summary & Long Hold Capital Preservation Plans - Newser
Volume spikes in Ventyx Biosciences Inc. stock – what they meanJuly 2025 Review & Technical Buy Zone Confirmation - Newser
Risk adjusted return profile for Ventyx Biosciences Inc. analyzed2025 Pullback Review & Free Verified High Yield Trade Plans - Newser
Technical analysis overview for Ventyx Biosciences Inc. stock2025 Market Overview & Verified High Yield Trade Plans - Newser
Is now a turning point for Ventyx Biosciences Inc.Fed Meeting & Weekly High Return Stock Forecasts - Newser
How to use Fibonacci retracement on Ventyx Biosciences Inc.July 2025 Breakouts & AI Driven Stock Price Forecasts - Newser
Is Ventyx Biosciences Inc. stock entering bullish territoryEarnings Growth Summary & Growth-Oriented Investment Plans - Newser
What MACD signals say about Ventyx Biosciences Inc.July 2025 Fed Impact & Daily Stock Trend Reports - Newser
Understanding Ventyx Biosciences Inc.’s price movement2025 Technical Patterns & Consistent Income Trade Recommendations - Newser
Applying chart zones and confluence areas to Ventyx Biosciences Inc.2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - Newser
What is the next catalyst for Ventyx Biosciences Inc.2025 Buyback Activity & Smart Investment Allocation Insights - khodrobank.com
Order flow analysis tools used on Ventyx Biosciences Inc.July 2025 PreEarnings & Verified Technical Trade Signals - Newser
Regression analysis insights on Ventyx Biosciences Inc. performanceTrade Entry Summary & Long Hold Capital Preservation Tips - Newser
What are the risks of holding Ventyx Biosciences Inc.2025 EndofYear Setup & Weekly Return Optimization Plans - khodrobank.com
Is Ventyx Biosciences Inc. benefiting from interest rate changesQuarterly Market Summary & High Return Trade Opportunity Guides - khodrobank.com
Is Ventyx Biosciences Inc. currently under institutional pressure2025 Year in Review & Real-Time Buy Signal Alerts - خودرو بانک
Is Ventyx Biosciences Inc. a potential multi bagger2025 Trading Recap & AI Powered Buy/Sell Recommendations - khodrobank.com
Trend Dashboard Flags Ventyx Biosciences Inc. As Potential Swing Trade getLinesFromResByArray error: size == 0 - kangso.co.kr
Building trade automation scripts for Ventyx Biosciences Inc.Quarterly Market Summary & High Accuracy Swing Entry Alerts - Newser
Using Bollinger Bands to evaluate Ventyx Biosciences Inc.July 2025 Closing Moves & Fast Gain Stock Trading Tips - Newser
Ventyx Biosciences Inc. Hits Price Floor — Bounce Incoming getLinesFromResByArray error: size == 0 - kangso.co.kr
Is Ventyx Biosciences Inc. forming a bottoming baseNew Guidance & Accurate Buy Signal Notifications - Newser
Why Ventyx Biosciences Inc. stock attracts strong analyst attentionWeekly Trade Analysis & Accurate Buy Signal Alerts - Newser
What technical models suggest about Ventyx Biosciences Inc.’s comebackRate Cut & Weekly Market Pulse Updates - Newser
Published on: 2025-08-31 02:29:30 - Newser
Ventyx Biosciences Inc. stock momentum explainedJuly 2025 Market Mood & Long-Term Safe Investment Ideas - Newser
What recovery options are there for Ventyx Biosciences Inc.Portfolio Risk Report & Free Expert Verified Stock Movement Alerts - Newser
Key resistance and support levels for Ventyx Biosciences Inc.July 2025 Price Swings & Advanced Technical Analysis Signals - Newser
What machine learning models say about Ventyx Biosciences Inc.2025 Analyst Calls & Trade Opportunity Analysis Reports - Newser
Has Ventyx Biosciences Inc. found a price floorPortfolio Risk Report & Real-Time Volume Spike Alerts - Newser
Full technical analysis of Ventyx Biosciences Inc. stockWeekly Investment Recap & Weekly High Conviction Ideas - Newser
Smart tools for monitoring Ventyx Biosciences Inc.’s price action2025 Top Decliners & Smart Swing Trading Techniques - Newser
How hedge fund analytics apply to Ventyx Biosciences Inc. stockPortfolio Risk Summary & Expert Verified Stock Movement Alerts - Newser
Finanzdaten der Ventyx Biosciences Inc-Aktie (VTYX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ventyx Biosciences Inc-Aktie (VTYX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mohan Raju | CEO AND PRESIDENT |
Mar 28 '25 |
Option Exercise |
0.00 |
11,844 |
0 |
2,303,540 |
| Nuss John | CHIEF SCIENTIFIC OFFICER |
Mar 28 '25 |
Option Exercise |
0.00 |
4,531 |
0 |
469,113 |
| Nuss John | CHIEF SCIENTIFIC OFFICER |
Dec 27 '24 |
Sale |
2.36 |
21,119 |
49,841 |
464,582 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):